Literature DB >> 6697586

Bone morphogenetic protein-induced cartilage development in tissue culture.

K Sato, M R Urist.   

Abstract

Outgrowths of mesenchyme-type cells from explants of allogeneic rat muscle onto a substratum of bone matrix containing bone morphogenetic protein (BMP) differentiate into cartilage. When BMP is chemically extracted from the bone matrix, the explanted cells develop only into fibrous tissue. When exogenous bovine BMP is introduced into the culture medium, either as a microsuspension or as a layer of particles between the matrix and the muscle cell tissue, cartilage develops at the interface between the matrix and the mesenchymal cell outgrowth. The chondrogenetic response is induced by as little as 2 micrograms of BMP; the optimum dose is 10 micrograms/40 mg (wet weight) of explant. The endogenous BMP equivalent for a comparable chondrogenetic response is about 0.6 micrograms/mg of allogeneic matrix. The minimum time for transfer of BMP to mesenchymal cell receptors is 1.0 hour, adequate time is 2.5 hours, and optimum time is approximately 5.0 hours. Measured in terms of incorporation of 3H-thymidine into DNA and of 35S sulfate into glycosaminoglycan, there is a latent period of one to three days preceeding the differentiation of mesenchyme-type cells into cartilage. During this latent period BMP-modulated mesenchymal cells disaggregate, migrate, reaggregate, and proliferate on new surfaces and constitute the morphogenetic phase of bone development. By the fourth day cells simultaneously undergo mitotic division, synthesize extracellular cartilage matrix, and establish the cytodifferentiation phase of development.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697586

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Bone transplantation.

Authors:  L Schweiberer; H Stützle; H K Mandelkow
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

2.  Repair of experimentally induced large osteochondral defects in rabbit knee with various concentrations of Escherichia coli-derived recombinant human bone morphogenetic protein-2.

Authors:  Yoshio Tokuhara; Shigeyuki Wakitani; Yuuki Imai; Amu Kawaguchi; Kenji Fukunaga; Mitsunari Kim; Yoshinori Kadoya; Kunio Takaoka
Journal:  Int Orthop       Date:  2009-06-16       Impact factor: 3.075

3.  Augmentation of osteochondral repair with hyperbaric oxygenation: a rabbit study.

Authors:  Alvin Chao-Yu Chen; Mel S Lee; Song-Shu Lin; Leou-Chuan Pan; Steve Wen-Neng Ueng
Journal:  J Orthop Surg Res       Date:  2010-12-06       Impact factor: 2.359

4.  Treatment of resting zone chondrocytes with bone morphogenetic protein-2 induces maturation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.

Authors:  Z Schwartz; V L Sylvia; Y Liu; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

5.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.

Authors:  A Yamaguchi; T Katagiri; T Ikeda; J M Wozney; V Rosen; E A Wang; A J Kahn; T Suda; S Yoshiki
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.